William E Monast
CIK 1411577 · EVP · last filed 2012-06-15
William E Monast is an EVP who has filed 14 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider bought $48.0K of PMC on Jun 15, 2012. Across all open-market trades the lifetime net is +$174.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.1K
2
14
$174.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PharMerica CORP (PMC) Delisted | EVP | 57,010 | — | — | $174.8K | 8 | 2012-06-15 |
| AHG | Exec. Vice President, Sales | 2,351 | $1.33 | $3.1K | $0 | 5 | 2008-09-08 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-15 | PharMerica CORP (PMC) Delisted | Buy (P) | +5,000 | $48.0K | EDGAR |
| 2012-03-28 | PharMerica CORP (PMC) Delisted | Tax (F) | −2,137 | -$26.6K | EDGAR |
| 2012-01-20 | PharMerica CORP (PMC) Delisted | Grant (A) | +25,885 | $0 | EDGAR |
| 2011-04-01 | PharMerica CORP (PMC) Delisted | Grant (A) | +18,262 | $0 | EDGAR |
| 2010-08-18 | PharMerica CORP (PMC) Delisted | Buy (P) | +3,500 | $26.2K | EDGAR |
| 2010-03-18 | PharMerica CORP (PMC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-11-24 | PharMerica CORP (PMC) Delisted | Buy (P) | +6,500 | $100.6K | EDGAR |
| 2009-04-22 | PharMerica CORP (PMC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-10-30 | — | Other (J) | −5,267 | $0 | |
| 2008-09-08 | AHG | Mixed | +3,213 | -$34.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.